Literature DB >> 25275762

Short-term total hip replacement outcomes in ankylosing spondylitis.

Susan M Goodman1, Rebecca Zhu, Mark P Figgie, Wei-Ti Huang, Lisa A Mandl.   

Abstract

BACKGROUND: While rates of total hip replacement (THR) in spondyloarthritis are increasing, contemporary outcomes are not well described.
OBJECTIVES: This study analyzes 2-year outcomes in a contemporary cohort of ankylosing spondylitis (AS) patients undergoing THR.
METHODS: A case-control study was performed using data from an institutional arthroplasty registry. Validated AS cases were matched 4:1 by age and procedure to patients with osteoarthritis (OA). Data were obtained prior to surgery and at 2 years. Multiple imputation techniques were performed to avoid systematic bias due to missing data.
RESULTS: Thirty eligible AS cases were identified between May 2007 and February 2010. Ankylosing spondylitis cases had worse American Society of Anesthesia class (P < 0.001) and more comorbidities (P = 0.02) compared with OA. Ankylosing spondylitis had worse preoperative lower-extremity Western Ontario and McMaster Universities Arthritis Index pain (46.8 vs 55.4; P = 0.03), function (43.0 vs 55.1; P = 0.04), and general health status measured as SF-12 (Short-Form Health Survey) physical component scale (PCS) score (29.6 vs 36.0; P < 0.001), however, there was no difference at two years in pain (89.4 vs 92.5; P = 0.23) or function (83.9 vs 90.1; P = 0.04). Physical component scale score remained significantly worse (41.2 vs 50.1; P < 0.001). Better preoperative SF-12 PCS score significantly decreased the risk of a poor pain outcome (odds ratio, 0.06; 95% confidence interval, 0.01-0.40). Overall satisfaction was high.
CONCLUSIONS: Although patients with AS in a contemporary cohort have more comorbidities and worse physical function prior to THR, they achieve similar gains as OA. In a multivariate regression controlling for multiple potential confounders including back pain, only preoperative health status measured as SF-12 PCS score was a significant risk factor for a poor 2-year pain. Among contemporary patients, AS is not an independent risk factor for poor THR outcomes.Take-Home Message Patients with AS have significant improvement in pain and function after THR.Poor preoperative function and low-back pain are not risk factors for poor THR outcomes for patients with AS.Despite improvements, low SF-12 PCS scores indicate persistent limitations due to health.

Entities:  

Mesh:

Year:  2014        PMID: 25275762     DOI: 10.1097/RHU.0000000000000138

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  5 in total

1.  Complications of Total Hip Arthroplasty in Patients With Ankylosing Spondylitis.

Authors:  Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-12-15       Impact factor: 4.794

2.  Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.

Authors:  Andrea Regel; Alexandre Sepriano; Xenofon Baraliakos; Désirée van der Heijde; Jürgen Braun; Robert Landewé; Filip Van den Bosch; Louise Falzon; Sofia Ramiro
Journal:  RMD Open       Date:  2017-01-27

3.  The correlation between volumetric bone mineral density and morphological parameters of the proximal femur and clinical outcomes in ankylosing spondylitis patients with hip involvement.

Authors:  Xinfeng Wu; Liang Zhang; Tao Bian; Siliang Man; Hongchao Li; Wei Liu; Yixin Zhou
Journal:  BMC Musculoskelet Disord       Date:  2022-01-03       Impact factor: 2.362

4.  Comparison of Outcomes of Total Hip Arthroplasty between Patients with Ankylosing Spondylitis and Avascular Necrosis of the Femoral Head.

Authors:  Sun-Ho Lee; Gun-Woo Lee; Young-Jun Seol; Kyung-Soon Park; Taek-Rim Yoon
Journal:  Clin Orthop Surg       Date:  2017-08-04

5.  Long-term Outcomes of Cemented Total Hip Arthroplasty in Patients with Ankylosing Spondylitis at a Minimum Follow-up of 10 Years.

Authors:  Soo Jae Yim; Yong Bok Park; Junyoung Kim; Sin Hyung Park
Journal:  Hip Pelvis       Date:  2018-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.